Press Releases on May 8, 2023 - EIN Presswire - Press Release Distribution Service

Published on May 8, 2023 - 20:01 GMT

Denali Therapeutics Reports First Quarter 2023 Financial Results and Business Highlights

SOUTH SAN FRANCISCO, Calif., May 08, 2023 (GLOBE NEWSWIRE) -- Denali Therapeutics Inc. (Nasdaq: DNLI), a biopharmaceutical company developing a broad portfolio of product candidates engineered to cross the blood-brain barrier (BBB) for the treatment of …

Distribution channels: Business & Economy, Technology ...

Published on May 8, 2023 - 20:01 GMT

HealthEquity Sets Date to Announce First Quarter Results Presentation at Conferences

DRAPER, Utah, May 08, 2023 (GLOBE NEWSWIRE) -- HealthEquity, Inc. (NASDAQ: HQY) (“HealthEquity” or the “Company”), the nation’s largest health savings account (“HSA") custodian, today announced plans to release its first quarter of fiscal 2024 …

Distribution channels: Culture, Society & Lifestyle, Healthcare & Pharmaceuticals Industry ...

Published on May 8, 2023 - 20:01 GMT

Ocular Therapeutix™ Provides First Quarter 2023 Financial Results and Corporate Update

12-month Top-Line Data from the U.S.-based Phase 1 Clinical Trial of OTX-TKI (axitinib intravitreal implant) for the Treatment of Wet AMD to be Presented in June at the Clinical Trials at the Summit 2023 Meeting Presented Pre-Clinical and Clinical Data on …

Distribution channels: Business & Economy, Culture, Society & Lifestyle ...

Published on May 8, 2023 - 20:01 GMT

FibroGen Reports First Quarter 2023 Financial Results

• Topline Data From Four Phase 3 Trials Expected Through 3Q 2023 • Completed Non-Dilutive Term Loan Financing for up to $150 Million with Morgan Stanley Tactical Value • Entered Into Exclusive License for FOR46 with Fortis Therapeutics SAN FRANCISCO, May …

Distribution channels: Business & Economy, Technology ...

Published on May 8, 2023 - 20:01 GMT

Corvus Pharmaceuticals Provides Business Update and Reports First Quarter 2023 Financial Results

Updated interim results from CPI-818 Phase 1/1b clinical trial continues to support potential of ITK inhibition and the ALC biomarker in T cell lymphoma Conference Call Today at 4:30 p.m. ET / 1:30 p.m. PT BURLINGAME, Calif., May 08, 2023 (GLOBE NEWSWIRE) …

Distribution channels: Business & Economy, Healthcare & Pharmaceuticals Industry ...

Published on May 8, 2023 - 20:01 GMT

CRISPR Therapeutics Provides Business Update and Reports First Quarter 2023 Financial Results

-Regulatory submissions complete for exagamglogene autotemcel (exa-cel), formerly known as CTX001™, in the U.S. for transfusion-dependent beta thalassemia (TDT) and severe sickle cell disease (SCD)- -EU and U.K. submissions validated by European Medicines …

Distribution channels: Business & Economy, Technology ...

Published on May 8, 2023 - 20:01 GMT

PetMed Express, Inc. Sets Fourth Quarter and Full Year 2023 Earnings Call

DELRAY BEACH, Fla., May 08, 2023 (GLOBE NEWSWIRE) -- PetMed Express, Inc. (PETS) (the “Company”), Your Trusted Pet Health Expert™ will hold a conference call on Monday, May 22, 2023 at 4:30pm Eastern time to discuss its financial results for the fourth …

Distribution channels: Healthcare & Pharmaceuticals Industry ...